<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112453509</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112453509</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chronic Hypoxia Impairs Cytochrome Oxidase Activity Via Oxidative Stress in Selected Fetal Guinea Pig Organs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Al-Hasan</surname>
<given-names>Yazan M.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112453509">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evans</surname>
<given-names>LaShauna C.</given-names>
</name>
<xref ref-type="aff" rid="aff1-1933719112453509">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pinkas</surname>
<given-names>Gerard A.</given-names>
</name>
<xref ref-type="aff" rid="aff2-1933719112453509">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dabkowski</surname>
<given-names>Erinne R.</given-names>
</name>
<xref ref-type="aff" rid="aff3-1933719112453509">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanley</surname>
<given-names>William C.</given-names>
</name>
<xref ref-type="aff" rid="aff3-1933719112453509">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Thompson</surname>
<given-names>Loren P.</given-names>
</name>
<xref ref-type="aff" rid="aff2-1933719112453509">2</xref>
<xref ref-type="corresp" rid="corresp1-1933719112453509"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112453509">
<label>1</label>Department of Physiology, University of Maryland, Baltimore, MD, USA</aff>
<aff id="aff2-1933719112453509">
<label>2</label>Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, MD, USA</aff>
<aff id="aff3-1933719112453509">
<label>3</label>Division of Cardiology, Department of Medicine, University of Maryland, Baltimore, MD, USA</aff>
<author-notes>
<corresp id="corresp1-1933719112453509">Loren P. Thompson, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, 655 W. Baltimore St., Bressler Research Building, Rm 11-029, Baltimore, MD 21201, USA. Email: <email>lthompson1@umm.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>3</issue>
<fpage>299</fpage>
<lpage>307</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>We hypothesized that chronic hypoxia disrupts mitochondrial function via oxidative stress in fetal organs. Pregnant guinea pig sows were exposed to either normoxia or hypoxia (10.5% O<sub>2</sub>, 14 days) in the presence or absence of the antioxidant, <italic>N</italic>-acetylcysteine (NAC). Near-term anesthetized fetuses were delivered via hysterotomy, and fetal livers, hearts, lungs, and forebrains harvested. We quantified the effects of chronic hypoxia on cytochrome oxidase (CCO) activity and 2 factors known to regulate CCO activity: malondialdehyde (MDA) and CCO subunit 4 (COX4). Hypoxia increased the MDA levels in fetal liver, heart, and lung with a corresponding reduction in CCO activity, prevented by prenatal NAC. The COX4 expression paralleled CCO activity in fetal liver and lung, but was unaltered in fetal hearts due to hypoxia. Hypoxia reduced the brain COX4 expression despite having no effect on CCO activity. This study identifies the mitochondrion as an important target site in tissue-specific oxidative stress for the induction of fetal hypoxic injury.</p>
</abstract>
<kwd-group>
<kwd>fetal</kwd>
<kwd>hypoxia</kwd>
<kwd>mitochondria</kwd>
<kwd>guinea pig</kwd>
<kwd>cytochrome c oxidase</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112453509">
<title>Introduction</title>
<p>Chronic intrauterine hypoxia can result from placental dysfunction, maternal complications, and living at high altitude.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112453509">1</xref>
</sup> Under conditions of reduced oxygenation, fetal development is compromised and results in intrauterine growth restriction (IUGR),<sup>
<xref ref-type="bibr" rid="bibr2-1933719112453509">2</xref>,<xref ref-type="bibr" rid="bibr3-1933719112453509">3</xref>
</sup> preterm birth, and respiratory distress syndrome.<sup>
<xref ref-type="bibr" rid="bibr4-1933719112453509">4</xref>
</sup> In more severe cases, IUGR can lead to still birth and perinatal mortality.<sup>
<xref ref-type="bibr" rid="bibr5-1933719112453509">5</xref>,<xref ref-type="bibr" rid="bibr6-1933719112453509">6</xref>
</sup> In the long term, growth restricted offspring has an increased risk of cardiovascular disease, metabolic syndromes, and pulmonary disease.<sup>
<xref ref-type="bibr" rid="bibr7-1933719112453509">7</xref>
</sup> Thus chronic intrauterine hypoxia is a leading cause of fetal morbidity and mortality whose consequences may impact the offspring through programming mechanisms, yet the underlying cellular mechanisms altered by fetal hypoxia remain largely unexplored.</p>
<p>Hypoxia has been demonstrated to cause oxidative stress in adult and fetal tissues.<sup>
<xref ref-type="bibr" rid="bibr8-1933719112453509">8</xref>
<xref ref-type="bibr" rid="bibr9-1933719112453509"/>
<xref ref-type="bibr" rid="bibr10-1933719112453509"/>–<xref ref-type="bibr" rid="bibr11-1933719112453509">11</xref>
</sup> Cellular damage by oxidative stress occurs as a result of excessive generation of reactive oxygen species (ROS) beyond the antioxidative capacity of the tissue.<sup>
<xref ref-type="bibr" rid="bibr12-1933719112453509">12</xref>
</sup> Reactive oxygen species can be generated by a variety of sources including the mitochondrial electron transport chain (ETC), xanthine oxidase, nicotinamide adenine dinucleotide phosphate oxidase, and other metabolic pathways such as β-oxidation.<sup>
<xref ref-type="bibr" rid="bibr13-1933719112453509">13</xref>,<xref ref-type="bibr" rid="bibr14-1933719112453509">14</xref>
</sup> Under conditions of reduced oxygen levels, when the ETC is compromised, the mitochondrion is a primary contributor of excessive electrons resulting in the generation of superoxide anions (O<sub>2</sub>
<sup>−</sup>) and oxidative stress. In the fetus, this can lead to adverse cellular effects including oxidation of lipids in the cellular membranes and mitochondrial dysfunction.</p>
<p>We have recently reported that chronic intrauterine hypoxia increases oxidative and nitrosative stress in fetal heart ventricles as evidenced by increased malondialdehyde (MDA), peroxynitrite, and 3-nitrotyrosine expression.<sup>
<xref ref-type="bibr" rid="bibr15-1933719112453509">15</xref>,<xref ref-type="bibr" rid="bibr16-1933719112453509">16</xref>
</sup> Additionally, studies have shown a link between chronic intrauterine hypoxia and oxidative stress in other fetal organs such as the brain.<sup>
<xref ref-type="bibr" rid="bibr17-1933719112453509">17</xref>
</sup>
</p>
<p>The mitochondria have been shown to be both generators of O<sub>2</sub>
<sup>−</sup> and targets of oxidative stress.<sup>
<xref ref-type="bibr" rid="bibr18-1933719112453509">18</xref>
<xref ref-type="bibr" rid="bibr19-1933719112453509"/>
<xref ref-type="bibr" rid="bibr20-1933719112453509"/>–<xref ref-type="bibr" rid="bibr21-1933719112453509">21</xref>
</sup> We propose that oxidative stress under conditions of chronic hypoxia could impact mitochondrial function and induce cellular injury. We tested the role of oxidative stress on fetal mitochondrial ETC function by administering the antioxidant, <italic>N</italic>-acetylcysteine (NAC), to normoxic and hypoxic (HPX) pregnant sows and measuring cytochrome oxidase (CCO) activity of near-term fetal organs. This enzyme is the major site of cellular O<sub>2</sub> consumption and is the terminal complex in the mitochondrial ETC which catalyzes the reduction of O<sub>2</sub> to H<sub>2</sub>O. The CCO is vulnerable to oxidative stress since it is inhibited by several oxidative species including MDA, a by-product of lipid peroxidation.<sup>
<xref ref-type="bibr" rid="bibr22-1933719112453509">22</xref>,<xref ref-type="bibr" rid="bibr23-1933719112453509">23</xref>
</sup> The CCO activity and assembly are regulated by expression of several catalytic and regulatory subunits such as COX4. This is a nuclear-encoded protein shown to be widely expressed and regulated under conditions of hypoxia.<sup>
<xref ref-type="bibr" rid="bibr24-1933719112453509">24</xref>
</sup> We hypothesized that COX4 expression may also regulate CCO activity in the context of fetal hypoxemia. A reduction in CCO activity would be expected to result in diminished adenosine triphosphate (ATP) synthesis and reduced energy production capacity in the affected tissues. This study will investigate the effects of hypoxia on mitochondrial CCO activity in fetal guinea pig liver, heart, lung, and brain, and the roles of MDA levels and COX4 expression in regulating CCO activity.</p>
</sec>
<sec id="section2-1933719112453509" sec-type="methods">
<title>Methods</title>
<sec id="section3-1933719112453509">
<title>Animal Model</title>
<p>Female Duncan-Hartley guinea pigs (term = 65 days) were purchased from a commercial breeder (Elm Hill Breeding Labs, Chelmsford, Massachusetts) and time-mated. Pregnant guinea pig sows were placed in a plexiglass chamber containing 10.5% O<sub>2</sub> for 14 days (hypoxic [HPX]) and normoxic controls were housed under normal room air (normoxic [NMX]; 21% O<sub>2</sub>).<sup>
<xref ref-type="bibr" rid="bibr17-1933719112453509">17</xref>
</sup> <italic>N</italic>-Acetylcysteine, at a dose of ∼580 mg NAC/kg per day, was administered in the drinking water to both hypoxic (HPX + NAC) and normoxic (NMX + NAC) animals for 10 days prior to tissue collection. The dose regimen selected was based on previous studies shown to inhibit oxidative responses in rats<sup>
<xref ref-type="bibr" rid="bibr25-1933719112453509">25</xref>
</sup> and guinea pigs.<sup>
<xref ref-type="bibr" rid="bibr26-1933719112453509">26</xref>
</sup> At near term (62-day gestation), pregnant sows were anesthetized with ketamine (80 mg/kg intraperitoneally [i.p.]) and xylazine (1 mg/kg i.p.), and given lidocaine, subcutaneously, along the midline of the abdomen. An abdominal incision was made and fetuses removed via hysterotomy. Fetal body weight and organ weights of liver, heart, brain, and placenta were measured at the time of excision and normalized to their respective fetal body weight (relative organ weight). Fetal liver (right lobe), heart (left ventricle), lung (right lobes), and brain (forebrain) were collected and snap frozen in liquid N<sub>2</sub> and stored at −80°C until analyzed. The methods employed were approved by University of Maryland Animal Care Committee and conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).</p>
</sec>
<sec id="section4-1933719112453509">
<title>Malondialdehyde Assay</title>
<p>Malondialdehyde, a product of lipid peroxidation, was measured by a thiobarbituric acid reactive substances (TBARS) assay as an index of oxidative stress. The MDA levels of frozen tissue homogenates (fetal liver, heart, lung, and brain) were quantified by TBARS assay per the manufacturer’s instructions (Cayman Chemical Company, Ann Arbor, Michigan). Briefly ∼30 mg of frozen tissues of each group were ground into powder using a mortar and pestle, lysed in radioimmunoprecipitation assay buffer (0.5 mol/L Tris-HCl, pH 7.4, 1.5 mol/L NaCl, 2.5% deoxycholic acid, 10% NP-40, 10 mmol/L EDTA), and spun at 1600<italic>g</italic> to remove cellular debris. The supernatant was incubated with the color reagent for 1 hour in boiling H<sub>2</sub>O (100°C). The MDA–TBA adduct of tissue homogenates formed at high temperatures is measured colorimetrically at 535 nm. Protein concentration was determined for each sample using the Bradford method<sup>
<xref ref-type="bibr" rid="bibr27-1933719112453509">27</xref>
</sup> and quantification of MDA expressed as nmols of MDA/mg protein.</p>
</sec>
<sec id="section5-1933719112453509">
<title>Mitochondrial Isolation and Cytochrome c Oxidase Assay</title>
<p>Enriched tissue mitochondrial fractions were generated in a similar manner as described by Gostimskaya and Galkin.<sup>
<xref ref-type="bibr" rid="bibr28-1933719112453509">28</xref>
</sup> Briefly, powdered frozen fetal guinea pig liver, heart, lung, and brain (30-50 mg) were homogenized in ice-cold mitochondrial isolation buffer (250 mmol/L sucrose, 5 mmol/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1 mmol/L EDTA, pH 7.5) in a Next Advance Bullet Blender for 5 minutes at power setting 9, and centrifuged in 4°C at 500<italic>g</italic> to remove cellular debris, the supernatant is then recentrifuged at high speed (12.5 × 1000<italic>g</italic>) to generate an enriched mitochondrial fraction. Total protein of each sample was determined using the Bradford method.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112453509">27</xref>
</sup>
</p>
<p>The CCO is the terminal complex of the ETC and the main site of O<sub>2</sub> consumption. The CCO activity was quantified by monitoring the oxidation rate of reduced cytochrome c after the addition of 0.5 µg isolated mitochondria solubilized with 0.05 mmol/L <italic>n</italic>-dodecyl-beta-<sc>d</sc>-maltoside at 550 nm in assay buffer (100 mmol/L K<sup>+</sup>PO<sub>4</sub>
<sup>−</sup>, pH 7.4, and 0.22 mmol/L reduced cytochrome c) in a 96-well plate reader and expressed as the units of CCO (µmoles of oxidized cytochrome c/min per mg of mitochondria).</p>
</sec>
<sec id="section6-1933719112453509">
<title>Mitochondrial Western Blot</title>
<p>The COX4, a subunit of CCO encoded in the nucleus, was analyzed using Western blot analysis. Briefly, 5 µg mitochondrial proteins from fetal liver, heart, lung, and brain were resolved on a 4 to 15% precast gradient sodium dodecyl sulfate–polyacrylamide electrophoresis gel and transferred to an Immun-Blot polyvinylidene difluoride (PVDF) membrane (Bio-Rad, Hercules, California). The membranes were then probed with a primary mouse monoclonal antibody (1/5000) that recognizes COX4 (Mitosciences, Eugene, Oregon, MS407) in 5% nonfat dry milk, over night at 4°C. Membranes were then incubated for 1 hour in 5% nonfat dry milk containing horseradish peroxidase-conjugated chicken anti-mouse secondary antibody (1:25 000, Santa Cruz Biotechnology, Santa Cruz, California). Bands were detected and visualized using ECL (Western Lightning Plus, Perkin Elmer, Waltham, Massachusetts) and quantified using densitometry in ImageJ (ImageJ, US National Institutes of Health, Bethesda, Maryland, <ext-link ext-link-type="uri" xlink:href="http://imagej.nih.gov/ij/">http://imagej.nih.gov/ij/</ext-link>). The intensity of COX4 was normalized to total mitochondrial protein as measured by Coomassie stain of the PVDF membrane and expressed as a ratio of COX4/Coomassie.</p>
</sec>
<sec id="section7-1933719112453509">
<title>Statistics</title>
<p>Data are expressed as mean ± standard error of the mean. A 2-way analysis of variance with hypoxia and drug treatment as independent variables was performed to determine statistical significance between means. Student-Newman-Keuls post hoc test was used to analyze the statistical significance between appropriate groups (NMX vs HPX, NMX vs NMX + NAC, and HPX vs HPX + NAC). A <italic>P</italic> value less than .05 is considered statistically significant.</p>
</sec>
</sec>
<sec id="section8-1933719112453509">
<title>Results</title>
<sec id="section9-1933719112453509">
<title>Effects of Hypoxia on Fetal Body Weight and Relative Placental and Brain Weights</title>
<p>Chronic intrauterine hypoxia reduces fetal body weight by 30.4% (<italic>P</italic> &lt; .001) compared to NMX controls from 88.97 ± 3.60 to 61.93 ± 2.73 g (<xref ref-type="fig" rid="fig1-1933719112453509">Figure 1</xref>). <italic>N</italic>-Acetylcysteine alone (NMX + NAC) reduced the fetal body weight by 13.5% (<italic>P</italic> &lt; .001) under normoxic conditions from 88.97 ± 3.60 to 76.94 ± 2.16 g (NMX + NAC) but did not the alter fetal body weight in hypoxic conditions. Chronic hypoxia increases the placenta: body weight ratio by 42.5% (<italic>P</italic> &lt; .001; 0.0512 ± 0.0019 [NMX] vs 0.0730 ± 0.0026 [HPX]). <italic>N</italic>-Acetylcysteine reduces the hypoxia-induced increase in relative placental weight by 13.0% (<italic>P</italic> &lt; .01; 0.0730 ± 0.0026 [HPX] vs 0.0635 ± 0.001 [HPX + NAC]). <italic>N</italic>-Acetylcysteine has no effect on the placenta: fetal body weight ratio in NMX animals. Chronic hypoxia reduces the fetal liver weight by 27.1% (<italic>P</italic> &lt; .05) compared to NMX controls from 4.20 ± 0.46 to 3.06 ± 0.28 g (HPX) but relative liver weight is unaffected. Hypoxia increases brain: body weight ratio by 31.2% (<italic>P</italic> &lt; .001) from 0.0292 ± 0.0005 (NMX) to 0.0383 ± 0.0013 (HPX). <italic>N</italic>-Acetylcysteine administration had no effect on the brain: body weight ratios in either NMX or HPX animals. Hypoxia increases the heart: body weight ratio by 10.7% (<italic>P</italic> &lt; .05) from 0.0056 ± 0.0002 (NMX) to 0.0062 ± 0.0003 (HPX). Administration of NAC had no effect on the heart: body weight ratios in either NMX or HPX animals.</p>
<fig id="fig1-1933719112453509" position="float">
<label>Figure 1.</label>
<caption>
<p>Fetal guinea pig body and organ weights. Relative organ weights of placenta, fetal liver, and fetal brain were normalized to their respective fetal body weight (g) and expressed as organ weight/body weight ratios. Fetuses were obtained from animals exposed to normoxia (NMX) or hypoxia (HPX) in the presence or absence of <italic>N</italic>-acetylcysteine (NAC). Data are mean ± standard error of the mean (SEM), ***<italic>P</italic> &lt; .001, **<italic>P</italic> &lt; .01 (NMX n = 8, HPX n = 9, HPX + NAC n = 8, and NMX + NAC n = 10).</p>
</caption>
<graphic xlink:href="10.1177_1933719112453509-fig1.tif"/>
</fig>
</sec>
<sec id="section10-1933719112453509">
<title>Effects of Hypoxia MDA Levels</title>
<p>Malondialdehyde is a product of lipid peroxidation and a marker of oxidative stress. Under normoxic conditions, MDA levels were similar between fetal liver, heart, and lung tissue but were slightly less in the fetal brain (<xref ref-type="fig" rid="fig2-1933719112453509">Figure 2</xref>). Chronic intrauterine hypoxia increases the MDA levels by 41.7% in fetal liver (1.27 ± 0.13 [NMX] vs 1.8 ± 0.07 [HPX] nmol MDA/mg protein, <italic>P</italic> &lt; .01), 70.7% in the fetal heart (1.01 ± 0.05 [NMX] vs 1.73 ± 0.17 [HPX], <italic>P</italic> &lt; .01), and 22.7% in fetal lung (0.66 ± 0.04 [NMX] vs 0.81 ± 0.03 [HPX], <italic>P</italic> &lt; .05) compared to their respective NMX controls. <italic>N</italic>-Acetylcysteine significantly reduces the hypoxia-induced increase in MDA levels in the fetal liver, heart, and lungs. The MDA levels in the fetal brain were not significantly altered either by hypoxia (0.64 ± 0.08 [NMX] vs 0.70 ± 0.14 [HPX]) or NAC treatment (0.52 ± 0.04 [NMX + NAC] vs 0.64 ± 0.14 [HPX + NAC]).</p>
<fig id="fig2-1933719112453509" position="float">
<label>Figure 2.</label>
<caption>
<p>Malondialdehyde (MDA) levels (nmoles/mg protein) of the fetal guinea pig liver, heart, lung, and brain. Fetal tissues were obtained from animals exposed to normoxia (NMX) or hypoxia (HPX) in the presence or absence of <italic>N</italic>-acetylcysteine (NAC). Data are mean ± standard error of the mean (SEM), **<italic>P</italic> &lt; .01, *<italic>P</italic> &lt; .05 (NMX n = 5, HPX n = 4-5, HPX + NAC n = 5-6, NMX + NAC n = 5-6).</p>
</caption>
<graphic xlink:href="10.1177_1933719112453509-fig2.tif"/>
</fig>
</sec>
<sec id="section11-1933719112453509">
<title>Effects of Hypoxia on CCO Activity</title>
<p>The CCO activity is measured as an index of mitochondrial ETC activity.<sup>
<xref ref-type="bibr" rid="bibr29-1933719112453509">29</xref>
</sup> Under normoxic conditions, CCO-specific activity units (µmoles of oxidized cytochrome c/min per mg of mitochondria) were highest in the heart (0.78 ± 0.04 units), followed by the lungs (0.28 ± 0.01 units), brain (0.21 ± 0.01 units), and liver (0.15 ± 0.01 units; <xref ref-type="fig" rid="fig3-1933719112453509">Figure 3</xref>). Chronic hypoxia reduces CCO activity in fetal liver (27.8%, <italic>P</italic> &lt; .05), heart (29.1%, <italic>P</italic> &lt; .05), and lungs (19.0%, <italic>P</italic> &lt; .05) compared to NMX controls but had no effect in the fetal brain. <italic>N</italic>-Acetylcysteine alone had no effect on CCO activity in NMX controls. However, NAC administration restores the hypoxia-induced decrease in CCO activity in fetal livers, hearts, and lungs to NMX levels but had no effect in the fetal brain.</p>
<fig id="fig3-1933719112453509" position="float">
<label>Figure 3.</label>
<caption>
<p>Cytochrome oxidase (CCO) activity of fetal guinea pig liver, heart, lung, and brain of animals exposed to normoxia (NMX) or hypoxia (HPX) in the presence or absence of <italic>N</italic>-acetylcysteine (NAC). Data are mean ± standard error of the mean (SEM) and expressed as CCO-specific activity (1 U = 1 μmol of oxidized cytochrome c/min per mg protein), *<italic>P</italic> &lt; .05. Fetal liver, lung, and brain NMX n = 8-12, HPX n = 9-12, HPX + NAC n = 8-12, NMX + NAC n = 10-12. Fetal heart (n = 5 for each group).</p>
</caption>
<graphic xlink:href="10.1177_1933719112453509-fig3.tif"/>
</fig>
</sec>
<sec id="section12-1933719112453509">
<title>Effects of Hypoxia on COX4 Expression</title>
<p>The CCO subunit 4 is a nuclear-encoded subunit of CCO and has been demonstrated to play an important role in regulating the stability of the mitochondria-encoded catalytic CCO subunit 1. <xref ref-type="fig" rid="fig4-1933719112453509">Figure 4</xref> illustrates representative Western immunoblots and the effects of hypoxia and NAC treatment on fetal liver, heart, lung, and brain COX4 protein expression. Chronic intrauterine hypoxia reduces COX4 subunit expression on fetal livers (15%, <italic>P</italic> &lt; .05), lungs (37%, <italic>P</italic> &lt; .05), and brains (26%, <italic>P</italic> &lt; .01) but has no effect in fetal hearts. <italic>N</italic>-Acetylcysteine prevents the hypoxia-induced decrease in COX4 expression in fetal livers and lungs but has no effect in fetal brains. In contrast, NAC increases COX4 expression in hypoxic fetal hearts but has no effect under conditions of NMX.</p>
<fig id="fig4-1933719112453509" position="float">
<label>Figure 4.</label>
<caption>
<p>Western blot analysis of cytochrome oxidase subunit 4 (COX4) protein expression of fetal guinea pig liver, heart, lung, and brain of animals exposed to normoxia (NMX) or hypoxia (HPX) in the presence or absence of <italic>N</italic>-acetylcysteine (NAC). Data are mean ± standard error of the mean (SEM). The COX4 expression is measured as a ratio of COX4 signal/Coomassie stain. *<italic>P</italic> &lt; .05. Molecular weight (MW) = 16 kDa. NMX n = 3-4, HPX n = 3-4, HPX + NAC n = 3-4, and NMX + NAC n = 3-4.</p>
</caption>
<graphic xlink:href="10.1177_1933719112453509-fig4.tif"/>
</fig>
</sec>
</sec>
<sec id="section13-1933719112453509">
<title>Discussion</title>
<p>This study indicates that chronic intrauterine hypoxia induces lipid peroxidation and impairs CCO activity in selected fetal organs. We found that chronic hypoxia increased the MDA levels in fetal livers, lungs, and hearts with a parallel reduction in CCO activity. The antioxidant, NAC, reversed the hypoxia-induced responses of both MDA levels and CCO activity. Chronic hypoxia had no effect on either MDA or CCO activity in fetal brains. The COX4 expression was reduced by chronic hypoxia in fetal livers and lungs, which may contribute to the observed decrease in CCO activity. In fetal hearts, however, COX4 expression was not altered by hypoxia and does not appear to contribute to the reduction in CCO activity. Taken together, these results suggest that the decrease in CCO activity by hypoxia in fetal livers, hearts, and lungs is mediated by the inhibitory effects of MDA on CCO activity,<sup>
<xref ref-type="bibr" rid="bibr22-1933719112453509">22</xref>
</sup> and the role of COX4 expression in modulating CCO activity differs among the fetal tissues. As expected, hypoxia reduced the fetal body weight, increased relative brain, heart and placental weights, and did not change relative liver weights as previously reported.<sup>
<xref ref-type="bibr" rid="bibr30-1933719112453509">30</xref>
</sup> <italic>N</italic>-Acetylcysteine did not affect any of the hypoxia-induced changes in body or organ weights except for a partial reduction in relative placental growth.</p>
<sec id="section14-1933719112453509">
<title>The Effects of Fetal Hypoxia on Mitochondrial Function</title>
<p>A decrease in tissue oxygen levels, as a result of fetal hypoxia can lead to decreased mitochondrial function. Under normoxic conditions, the ETC transfers electrons along complexes I (or II), III, and IV to the final electron acceptor, O<sub>2</sub>, to generate a pH gradient that drives the production of ATP. The CCO is the terminal complex of the ETC and the major site of cellular O<sub>2</sub> reduction to H<sub>2</sub>O. Its activity is a key regulator of overall mitochondrial oxidative phosphorylation and ATP production.<sup>
<xref ref-type="bibr" rid="bibr31-1933719112453509">31</xref>
<xref ref-type="bibr" rid="bibr32-1933719112453509"/>
<xref ref-type="bibr" rid="bibr33-1933719112453509"/>
<xref ref-type="bibr" rid="bibr34-1933719112453509"/>–<xref ref-type="bibr" rid="bibr35-1933719112453509">35</xref>
</sup> During hypoxia, the decrease in O<sub>2</sub> concentration reduces the electron flow through the mitochondrial ETC resulting in an excess of electrons that interact with oxygen containing moieties or with molecular O<sub>2</sub> to generate superoxide anions (O<sub>2</sub>
<sup>−</sup>).<sup>
<xref ref-type="bibr" rid="bibr36-1933719112453509">36</xref>
<xref ref-type="bibr" rid="bibr37-1933719112453509"/>
<xref ref-type="bibr" rid="bibr38-1933719112453509"/>
<xref ref-type="bibr" rid="bibr39-1933719112453509"/>–<xref ref-type="bibr" rid="bibr40-1933719112453509">40</xref>
</sup> As a result, the mitochondria of hypoxic tissues may be the generators of ROS, which can react with biological macromolecules leading to organelle dysfunction and cellular damage.</p>
<p>Peroxidation of cellular lipids produces MDA, a highly reactive lipid peroxide that forms adducts with CCO, antagonizes its activity, and reduces ETC function.<sup>
<xref ref-type="bibr" rid="bibr22-1933719112453509">22</xref>
</sup> The elevation of MDA levels in fetal organ generated by hypoxia would be expected to inhibit the activity of CCO and reduce the mitochondrial capacity of ATP synthesis. The restorative effects of NAC on CCO activity indicate an inhibitory effect of oxidative stress on ETC function. This is evident in the fetal liver, lung, and heart but does not occur in the fetal forebrain. The lack of increase in fetal brain MDA was surprising given previous reports of hypoxic stress in the fetal guinea pig brain under similar conditions<sup>
<xref ref-type="bibr" rid="bibr17-1933719112453509">17</xref>
</sup> but is consistent with the lack of increase in CCO activity if MDA is an inhibitory factor. The organ-specific variability may be due to the differences in relative tissue hypoxia, MDA formation, or the antioxidant capacity of the fetal organs. Thus, in hypoxic fetal organs, where MDA levels are increased, this may be an important regulatory factor of CCO activity and oxidative phosphorylation.</p>
</sec>
<sec id="section15-1933719112453509">
<title>The Effects of Fetal Hypoxia on COX Expression</title>
<p>The CCO is located in the mitochondrial inner membrane and is a dimer of monomers consisting of 13 subunits.<sup>
<xref ref-type="bibr" rid="bibr29-1933719112453509">29</xref>
</sup> The CCO assembly is an important step in regulating catalytic core activity. This regulation is largely dependent on subunit expression and interaction that modulate and stabilize core formation and assembly.<sup>
<xref ref-type="bibr" rid="bibr41-1933719112453509">41</xref>,<xref ref-type="bibr" rid="bibr42-1933719112453509">42</xref>
</sup> Cytochrome oxidase subunit 4 mediates the progression of CCO assembly.<sup>
<xref ref-type="bibr" rid="bibr43-1933719112453509">43</xref>
</sup> Furthermore, COX4 expression is regulated by O<sub>2</sub> availability and is degraded by the hypoxia-inducible factor-1α (HIF-1α)-activated mitochondrial protease, Lon, reported to be increased during hypoxia.<sup>
<xref ref-type="bibr" rid="bibr24-1933719112453509">24</xref>,<xref ref-type="bibr" rid="bibr44-1933719112453509">44</xref>
<xref ref-type="bibr" rid="bibr45-1933719112453509"/>–<xref ref-type="bibr" rid="bibr46-1933719112453509">46</xref>
</sup> Thus, a downregulation of COX4 expression and reduction in CCO assembly and activity would be expected to occur under conditions of fetal hypoxia and elevated HIF-1α levels.<sup>
<xref ref-type="bibr" rid="bibr47-1933719112453509">47</xref>
</sup>
</p>
<p>The expression of COX4 in the lung and liver of fetal guinea pig parallels the pattern of CCO activity associated with both hypoxia and hypoxia + NAC. The observation that hypoxia reduces COX4 expression is in agreement with the expected elevation in HIF-1α and Lon levels, presumed to occur during fetal hypoxia. However, the restoration of liver and lung COX4 levels in the presence of HPX + NAC suggests that COX4 is regulated by oxidative stress rather than hypoxia since O<sub>2</sub> levels would be expected to remain low in the presence of NAC treatment. This is supported by the sustained brain sparing effect in the presence of HPX + NAC. Previous studies have implicated Lon protease as a factor in degrading oxidized mitochondrial proteins such as COX4.<sup>
<xref ref-type="bibr" rid="bibr46-1933719112453509">46</xref>,<xref ref-type="bibr" rid="bibr48-1933719112453509">48</xref>
</sup> Thus, NAC may restore COX4 expression by decreasing oxygen radicals in hypoxic fetal guinea pig lungs and livers and preventing oxidation of COX4. However, the effect of NAC differs among fetal organs. In the fetal brain, hypoxia decreased COX4 expression, which was insensitive to NAC. This suggests that the COX4 expression in the fetal brain is regulated independently of oxidative stress. Furthermore, because the reduction in brain COX4 expression did not correspond to a reduction in CCO activity, we hypothesize that COX4 plays a diminished role in regulating brain CCO activity. In fetal hearts, COX4 expression was unaltered by hypoxia, although CCO activity was inhibited. Thus, fetal cardiac CCO activity is likely regulated by MDA in a manner independent of COX4 expression. The differential regulation of COX4 expression by hypoxia and NAC among these fetal organs likely reflects tissue-specific variations in response to hypoxia and generation of oxidative stress. Further, the role of COX4 and its involvement in CCO complex assembly<sup>
<xref ref-type="bibr" rid="bibr41-1933719112453509">41</xref>
</sup> may vary between fetal tissues. Finally, our understanding of the regulation of COX4-specific expression in ETC function is derived from a variety of cell types (ie, isolated cancer cells) and conditions (acute in vitro responses) that may be distinct from those of the current study using chronically hypoxic fetal organs. Yet, this study presents a mitochondrial response in the fetus that may elucidate organ-specific challenges to chronic hypoxic stress.</p>
<p>In summary, we studied the effects of chronic hypoxia on tissue-specific regulation of CCO activity by measuring MDA and COX4 expression, 2 factors known to modulate the activity of this enzyme. Our results demonstrate an increase in MDA levels in fetal liver, heart, and lung after chronic intrauterine hypoxia and a concomitant reduction in CCO activity. In the hypoxic fetal brain, a lack of decrease in CCO activity is consistent with a lack of increase in MDA levels. Under conditions of increased MDA, CCO activity was prevented by the antioxidant, NAC. On the other hand, COX4 expression parallels CCO activity in the fetal lung and liver but not in the fetal brain and heart, identifying differences among fetal organs associated with the role of COX4 expression and CCO activity. This study identifies the tissue-specific effects of hypoxia on oxidative stress that lead to a corresponding reduction in mitochondrial function in the fetus. Treatment during gestation may help reverse the effects of intrauterine hypoxia on mitochondrial dysfunction by reducing the ROS-generated inhibitory effects of MDA and other lipid peroxidation products.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-1933719112453509">
<label>Authors’ Note</label>
<p>The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.</p>
</fn>
<fn fn-type="conflict" id="fn2-1933719112453509">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-1933719112453509">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: in part by <grant-sponsor>NIH</grant-sponsor><?release-delay 12|0?> Grants <grant-num>R01HL 49999</grant-num> (LPT) and <grant-num>T32-HL072757</grant-num> (YMA). </p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112453509">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myatt</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Placental adaptive responses and fetal programming</article-title>. <source>J Physiol</source>. <year>2006</year>;<volume>572</volume>(<issue>pt 1</issue>):<fpage>25</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112453509">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kingdom</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Oxygen and placental villous development: origins of fetal hypoxia</article-title>. <source>Placenta</source>. <year>1997</year>;<volume>18</volume>(<issue>8</issue>):<fpage>613</fpage>–<lpage>621</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112453509">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giaccia</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease</article-title>. <source>Genes Dev</source>. <year>2004</year>;<volume>18</volume>(<issue>18</issue>):<fpage>2183</fpage>–<lpage>2194</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112453509">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilbert</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Danielsen</surname>
<given-names>B.</given-names>
</name>
</person-group> <article-title>Pregnancy outcomes associated with intrauterine growth restriction</article-title>. <source>Am J Obstet Gynecol</source>. <year>2003</year>;<volume>188</volume>(<issue>6</issue>):<fpage>1596</fpage>–<lpage>1599</lpage>; <comment>discussion 1599-1601</comment>.</citation>
</ref>
<ref id="bibr5-1933719112453509">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Séguin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lydon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goulet</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Socio-economic disparities in pregnancy outcome: why do the poor fare so poorly?</article-title> <source>Paediatr Perinat Epidemiol</source>. <year>2000</year>;<volume>14</volume>(<issue>3</issue>):<fpage>194</fpage>–<lpage>210</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112453509">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Julian</surname>
<given-names>CG.</given-names>
</name>
</person-group> <article-title>High altitude during pregnancy</article-title>. <source>Clin Chest Med</source>. <year>2011</year>;<volume>32</volume>(<issue>1</issue>):<fpage>21</fpage>–<lpage>31</lpage>, vii.</citation>
</ref>
<ref id="bibr7-1933719112453509">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barker</surname>
<given-names>DJ</given-names>
</name>
</person-group>. <article-title>The fetal and infant origins of adult disease</article-title>. <source>BMJ</source>. <year>1990</year>;<volume>301</volume>(<issue>6761</issue>):<fpage>1111</fpage>.</citation>
</ref>
<ref id="bibr8-1933719112453509">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guzy</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Hoyos</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing</article-title>. <source>Cell Metab</source>. <year>2005</year>;<volume>1</volume>(<issue>6</issue>):<fpage>401</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112453509">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>AB.</given-names>
</name>
</person-group> <article-title>Activation of endothelial NADPH oxidase as the source of a reactive oxygen species in lung ischemia</article-title>. <source>Chest</source>. <year>1999</year>;<volume>116</volume>(<issue>1 suppl</issue>):<fpage>25S</fpage>–<lpage>26S</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112453509">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Killilea</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Hester</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Balczon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Babal</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gillespie</surname>
<given-names>MN</given-names>
</name>
</person-group>. <article-title>Free radical production in hypoxic pulmonary artery smooth muscle cells</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>. <year>2000</year>;<volume>279</volume>(<issue>2</issue>):<fpage>L408</fpage>–<lpage>L412</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112453509">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buonocore</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Perrone</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Longini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Terzuoli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bracci</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies</article-title>. <source>Pediatr Res</source>. <year>2000</year>;<volume>47</volume>(<issue>2</issue>):<fpage>221</fpage>–<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112453509">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raza</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Prabu</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>John</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Avadhani</surname>
<given-names>NG</given-names>
</name>
</person-group>. <article-title>Impaired mitochondrial respiratory functions and oxidative stress in streptozotocin-induced diabetic rats</article-title>. <source>Int J Mol Sci</source>. <year>2011</year>;<volume>12</volume>(<issue>5</issue>):<fpage>3133</fpage>–<lpage>3147</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112453509">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leibfritz</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Moncol</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>MTD</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Telser</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title>. <source>Int J Biochem Cell Biol</source>. <year>2007</year>;<volume>39</volume>(<issue>1</issue>):<fpage>44</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112453509">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedard</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heinz</surname>
<given-names>KK</given-names>
</name>
</person-group>. <article-title>The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology</article-title>. <source>Physiol Rev</source>. <year>2007</year>;<volume>87</volume>(<issue>1</issue>):<fpage>245</fpage>–<lpage>313</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112453509">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Chronic hypoxia increases inducible NOS-derived nitric oxide in fetal guinea pig hearts</article-title>. <source>Pediatr Res</source>. <year>2009</year>;<volume>65</volume>(<issue>2</issue>):<fpage>188</fpage>–<lpage>192</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112453509">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>LSC</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pinkas</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>LP</given-names>
</name>
</person-group>. <article-title>Chronic hypoxia increases peroxynitrite, MMP9 expression, and collagen accumulation in fetal guinea pig hearts</article-title>. <source>Pediatr Res</source>. <year>2012</year>;<volume>71</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112453509">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Chronic fetal hypoxia produces selective brain injury associated with altered nitric oxide synthases</article-title>. <source>Am J Obstet Gynecol</source>. <year>2011</year>;<volume>204</volume>(<issue>3</issue>):254.<fpage>e16</fpage>–<lpage>e28</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112453509">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cortassa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>O’Rourke</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Redox-optimized ROS balance: a unifying hypothesis</article-title>. <source>Biochim Biophys Acta</source>. <year>2010</year>;<volume>1797</volume>(<issue>6-7</issue>):<fpage>865</fpage>–<lpage>877</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112453509">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demin</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Kholodenko</surname>
<given-names>BN</given-names>
</name>
<name>
<surname>Skulachev</surname>
<given-names>VP</given-names>
</name>
</person-group>. <article-title>A model of O2-generation in the complex III of the electron transport chain</article-title>. <source>Mol Cell Biochem</source>. <year>1998</year>;<volume>184</volume>(<issue>1-2</issue>):<fpage>21</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112453509">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miwa</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brand</surname>
<given-names>MD</given-names>
</name>
</person-group>. <article-title>Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling</article-title>. <source>Biochem Soc Trans</source>. <year>2003</year>;<volume>31</volume>(<issue>pt 6</issue>):<fpage>1300</fpage>–<lpage>1301</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112453509">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Vazquez</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Moghaddas</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoppel</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Lesnefsky</surname>
<given-names>EJ</given-names>
</name>
</person-group>. <article-title>Production of reactive oxygen species by mitochondria: central role of complex III</article-title>. <source>J Biol Chem</source>. <year>2003</year>;<volume>278</volume>(<issue>38</issue>):<fpage>36027</fpage>–<lpage>36031</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112453509">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Schenker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Henderson</surname>
<given-names>GI</given-names>
</name>
</person-group>. <article-title>Formation of malondialdehyde adducts in livers of rats exposed to ethanol: role in ethanol-mediated inhibition of cytochrome c oxidase</article-title>. <source>Alcohol Clin Exp Res</source>. <year>2000</year>;<volume>24</volume>(<issue>4</issue>):<fpage>544</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112453509">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Araneda</surname>
<given-names>OF</given-names>
</name>
<name>
<surname>Llanos</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Celedón</surname>
<given-names>G</given-names>
</name>
<name>
<surname>González</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Hypoxia-related lipid peroxidation: evidences, implications and approaches</article-title>. <source>Respir Physiol Neurobiol</source>. <year>2007</year>;<volume>158</volume>(<issue>2-3</issue>):<fpage>143</fpage>–<lpage>150</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112453509">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Whan</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Shimoda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>CV</given-names>
</name>
<name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</name>
</person-group>. <article-title>HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells</article-title>. <source>Cell</source>. <year>2007</year>;<volume>129</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112453509">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beloosesky</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gayle</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Amidi</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats</article-title>. <source>Am J Obstet Gynecol</source>. <year>2006</year>;<volume>194</volume>(<issue>1</issue>):<fpage>268</fpage>–<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112453509">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B-J</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y-L</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H-Y</given-names>
</name>
<etal/>
</person-group> <article-title>N-acetylcysteine inhibits chromium hypersensitivity in coadjuvant chromium-sensitized albino guinea pigs by suppressing the effects of reactive oxygen species</article-title>. <source>Exp Dermatol</source>. <year>2010</year>;<volume>19</volume>(<issue>8</issue>):<fpage>e191</fpage>–<lpage>e200</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112453509">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradford</surname>
<given-names>MM</given-names>
</name>
</person-group>. <article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title>. <source>Anal Biochem</source>. <year>1976</year>;<volume>72</volume>:<fpage>248</fpage>–<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112453509">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gostimskaya</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Galkin</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Preparation of highly coupled rat heart mitochondria</article-title>. <source>J Vis Exp</source>. <year>2010</year>;(<issue>43</issue>):<fpage>3</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112453509">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kadenbach</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Huttemann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bender</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase1</article-title>. <source>Free Radic Biol Med</source>. <year>2000</year>;<volume>29</volume>(<issue>3-4</issue>):<fpage>211</fpage>–<lpage>221</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112453509">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>LP.</given-names>
</name>
</person-group> <article-title>Intrauterine hypoxia upregulates proinflammatory cytokines and matrix metalloproteinases in fetal guinea pig hearts</article-title>. <source>Am J Obstet Gynecol</source>. <year>2008</year>;<volume>199</volume>(<issue>1</issue>):78.<fpage>e1</fpage>–<lpage>e6</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112453509">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacelli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Latorre</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cocco</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Tight control of mitochondrial membrane potential by cytochrome c oxidase</article-title>. <source>Mitochondrion</source>. <year>2011</year>;<volume>11</volume>(<issue>2</issue>):<fpage>334</fpage>–<lpage>341</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112453509">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Attardi</surname>
<given-names>G.</given-names>
</name>
</person-group> <article-title>In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1997</year>;<volume>94</volume>(<issue>4</issue>):<fpage>1166</fpage>–<lpage>1171</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112453509">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hüttemann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Helling</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sanderson</surname>
<given-names>TH</given-names>
</name>
<etal/>
</person-group> <article-title>Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation</article-title>. <source>Biochim Biophys Acta</source>. <year>2012</year>;<volume>1817</volume>(<issue>4</issue>):<fpage>598</fpage>–<lpage>609</lpage>.</citation>
</ref>
<ref id="bibr34-1933719112453509">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hájek</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Villani</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Attardi</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Rate-limiting step preceding cytochrome c release in cells primed for Fas-mediated apoptosis revealed by analysis of cellular mosaicism of respiratory changes</article-title>. <source>J Biol Chem</source>. <year>2001</year>;<volume>276</volume>(<issue>1</issue>):<fpage>606</fpage>–<lpage>615</lpage>.</citation>
</ref>
<ref id="bibr35-1933719112453509">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunz</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Kudin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vielhaber</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Elger</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Attardi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Villani</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Flux control of cytochrome c oxidase in human skeletal muscle</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>36</issue>):<fpage>27741</fpage>–<lpage>27745</lpage>.</citation>
</ref>
<ref id="bibr36-1933719112453509">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandel</surname>
<given-names>NS</given-names>
</name>
<name>
<surname>McClintock</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Feliciano</surname>
<given-names>CE</given-names>
</name>
<etal/>
</person-group> <article-title>Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>33</issue>):<fpage>25130</fpage>–<lpage>25138</lpage>.</citation>
</ref>
<ref id="bibr37-1933719112453509">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waypa</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Schumacker</surname>
<given-names>PT</given-names>
</name>
</person-group>. <article-title>Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing</article-title>. <source>J Appl Physiol</source>. <year>2005</year>;<volume>98</volume>(<issue>1</issue>):<fpage>404</fpage>–<lpage>414</lpage>.</citation>
</ref>
<ref id="bibr38-1933719112453509">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassanein</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Frederick</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Mitochondrial dysfunction in liver disease and organ transplantation</article-title>. <source>Mitochondrion</source>. <year>2004</year>;<volume>4</volume>(<issue>5-6</issue>):<fpage>609</fpage>–<lpage>620</lpage>.</citation>
</ref>
<ref id="bibr39-1933719112453509">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schönfeld</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Schlüter</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>K-D</given-names>
</name>
<name>
<surname>Reiser</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Non-esterified polyunsaturated fatty acids distinctly modulate the mitochondrial and cellular ROS production in normoxia and hypoxia</article-title>. <source>J Neurochem</source>. <year>2011</year>;<volume>118</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr40-1933719112453509">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turrens</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Mitochondrial formation of reactive oxygen species</article-title>. <source>J Physiol</source>. <year>2003</year>;<volume>552</volume>(<issue>pt 2</issue>):<fpage>335</fpage>–<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr41-1933719112453509">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontanesi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Soto</surname>
<given-names>IC</given-names>
</name>
<name>
<surname>Barrientos</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Cytochrome c oxidase biogenesis: new levels of regulation</article-title>. <source>IUBMB Life</source>. <year>2008</year>;<volume>60</volume>(<issue>9</issue>):<fpage>557</fpage>–<lpage>568</lpage>.</citation>
</ref>
<ref id="bibr42-1933719112453509">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fornuskova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stiburek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wenchich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vinsova</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansikova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zeman</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b</article-title>. <source>Biochem J</source>. <year>2010</year>;<volume>428</volume>(<issue>3</issue>):<fpage>363</fpage>–<lpage>374</lpage>.</citation>
</ref>
<ref id="bibr43-1933719112453509">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stiburek</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vesela</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansikova</surname>
<given-names>H</given-names>
</name>
<etal/>
</person-group> <article-title>Tissue-specific cytochrome c oxidase assembly defects due to mutations in SCO2 and SURF1</article-title>. <source>Biochem J</source>. <year>2005</year>;<volume>392</volume>(<issue>pt 3</issue>):<fpage>625</fpage>–<lpage>632</lpage>.</citation>
</ref>
<ref id="bibr44-1933719112453509">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hervouet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pecina</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Demont</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Inhibition of cytochrome c oxidase subunit 4 precursor processing by the hypoxia mimic cobalt chloride</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2006</year>;<volume>344</volume>(<issue>4</issue>):<fpage>1086</fpage>–<lpage>1093</lpage>.</citation>
</ref>
<ref id="bibr45-1933719112453509">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</name>
</person-group>. <article-title>Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1</article-title>. <source>Biochem J</source>. <year>2007</year>;<volume>405</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr46-1933719112453509">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gibellini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De Biasi</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Functional characterization of the promoter of the human Lon protease gene</article-title>. <source>Mitochondrion</source>. <year>2011</year>;<volume>11</volume>(<issue>1</issue>):<fpage>200</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr47-1933719112453509">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haddad</surname>
<given-names>JJ</given-names>
</name>
</person-group>. <article-title>Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors</article-title>. <source>Cell Signal</source>. <year>2002</year>;<volume>14</volume>(<issue>11</issue>):<fpage>879</fpage>–<lpage>897</lpage>.</citation>
</ref>
<ref id="bibr48-1933719112453509">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatsuta</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Langer</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Quality control of mitochondria: protection against neurodegeneration and ageing</article-title>. <source>EMBO J</source>. <year>2008</year>;<volume>27</volume>(<issue>2</issue>):<fpage>306</fpage>–<lpage>314</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>